Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 781 AL 795

Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies

Alkhalifa AE, Al-Ghraiybah NF, Odum J, Shunnarah JG, Austin N, Kaddoumi A.

Int J Mol Sci. 2023 Nov 14;24(22):16288. doi: 10.3390/ijms242216288.

Iron and Targeted Iron Therapy in Alzheimer's Disease

Wang J, Fu J, Zhao Y, Liu Q, Yan X, Su J.

Int J Mol Sci. 2023 Nov 15;24(22):16353. doi: 10.3390/ijms242216353.

The Role of Insulin-like Growth Factor I in Mechanisms of Resilience and Vulnerability to Sporadic Alzheimer's Disease

Zegarra-Valdivia JA, Pignatelli J, Nuñez A, Torres Aleman I.

Int J Mol Sci. 2023 Nov 17;24(22):16440. doi: 10.3390/ijms242216440.

Topical Cellular/Tissue and Molecular Aspects Regarding Nonpharmacological Interventions in Alzheimer's Disease-A Systematic Review

Aurelian S, Ciobanu A, Cărare R, Stoica SI, Anghelescu A, Ciobanu V, Onose G, Munteanu C, Popescu C, Andone I, Spînu A, Firan C, Cazacu IS, Trandafir AI, Băilă M, Postoiu RL, Zamfirescu A.

Int J Mol Sci. 2023 Nov 20;24(22):16533. doi: 10.3390/ijms242216533.

Research Progress on Natural Plant Molecules in Regulating the Blood-Brain Barrier in Alzheimer's Disease

Wu W, Huang J, Han P, Zhang J, Wang Y, Jin F, Zhou Y.

Molecules. 2023 Nov 16;28(22):7631. doi: 10.3390/molecules28227631.

TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease

Shulman M, Kong J, O'Gorman J, Ratti E, Rajagovindan R, Viollet L, Huang E, Sharma S, Racine AM, Czerkowicz J, Graham D, Li Y, Hering H, Haeberlein SB.

Nat Aging. 2023 Dec;3(12):1591-1601. doi: 10.1038/s43587-023-00523-w. Epub 2023 Nov 27.

Alzheimer Disease: A New Beginning in Therapeutics

Honig LS.

Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01;37(4):267-269. doi: 10.1097/WAD.0000000000000592. Epub 2023 Nov 28.

Novel APOE Mutation in a Moroccan Subject Suffering from Alzheimer Disease: A Case Study and Exploration of Pathogenic Implication

Razouqi Y, El Bouchikhi I, El-Abid H, Baammi S, Nedbour A, Touhami Ahami AO, El Allali A, Bouguenouch L.

Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01;37(4):370-372. doi: 10.1097/WAD.0000000000000590. Epub 2023 Nov 28.

Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease

Terzioglu G, Young-Pearse TL.

Mol Neurodegener. 2023 Nov 29;18(1):89. doi: 10.1186/s13024-023-00674-9.

Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer's Disease

Rajput S, Malviya R, Bahadur S, Puri D.

Curr Pharm Des. 2023;29(35):2802-2813. doi: 10.2174/0113816128274618231105173031.

[Beneficial effects of ketogenic diet for Alzheimer's disease management]

Charlot A, Lernould A, Plus I, Zoll J.

Biol Aujourdhui. 2023;217(3-4):253-263. doi: 10.1051/jbio/2023031. Epub 2023 Nov 29.

The Role of Traditional Chinese Medicine Natural Products in β-Amyloid Deposition and Tau Protein Hyperphosphorylation in Alzheimer's Disease

Yan H, Feng L, Li M.

Drug Des Devel Ther. 2023 Nov 13;17:3295-3323. doi: 10.2147/DDDT.S380612. eCollection 2023.

Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease

Marei HE, Khan MUA, Hasan A.

Cell Mol Biol Lett. 2023 Nov 30;28(1):98. doi: 10.1186/s11658-023-00504-2.

Economic Evaluation of Exercise or Cognitive and Social Enrichment Activities for Improved Cognition After Stroke

Adjetey C, Davis JC, Falck RS, Best JR, Dao E, Bennett K, Tai D, McGuire K, Eng JJ, Hsiung GR, Middleton LE, Hall PA, Hu M, Sakakibara BM, Liu-Ambrose T.

JAMA Netw Open. 2023 Nov 1;6(11):e2345687. doi: 10.1001/jamanetworkopen.2023.45687.

A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease

Kashif M, Sivaprakasam P, Vijendra P, Waseem M, Pandurangan AK.

Curr Pharm Des. 2023;29(43):3428-3441. doi: 10.2174/0113816128264355231121064704.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias